FDA clears LabCorp's COVID-19 test for asymptomatic use

By Kate Madden Yee, LabPulse.com contributing writer

July 27, 2020 -- The U.S. Food and Drug Administration (FDA) has cleared LabCorp's COVID-19 reverse transcription polymerase chain reaction (RT-PCR) test for use in screening asymptomatic people.

The agency renewed emergency use authorization (EUA) for LabCorp's assay with two new applications: testing asymptomatic individuals and allowing for pooled testing with up to five individual swab specimens.

"[The] FDA's authorization of the first diagnostic test to be used for anyone, regardless of whether they are showing symptoms of COVID-19 or have other exposure risk factors, is a step toward the type of broad screening that may help enable the reopening of schools and workplaces," said FDA Commissioner Dr. Stephen Hahn in a statement released by the agency.

LabCorp's test is available by prescription only but may be used at home with the company's Pixel home collection kits as well as by a healthcare provider, although pooled samples must be collected by a healthcare provider, the FDA said.

The agency paved the way for tests screening asymptomatic people through guidance issued in June.

LabCorp launches smart laboratory test reports
LabCorp has launched Insight Analytics, intelligent reports that combine national laboratory test values with patient demographics.
Humana offers LabCorp at-home COVID-19 test, partners with Walmart, Quest
Health insurer Humana is offering LabCorp's at-home COVID-19 test kit in a pilot home testing program for members. It has also formed a new collaboration...
LabCorp neutralizing antibody test could help screen recovered COVID-19 patients
LabCorp has launched a new neutralizing antibody test that it says will be useful in the development of vaccines and in screening the plasma of recovered...
FDA paves way for mass coronavirus screening of asymptomatic people
The U.S. Food and Drug Administration (FDA) has published guidance for diagnostics developers that it said will enable broad diagnostic testing of asymptomatic...
LabCorp gives employers a hand with screening staff for coronavirus
LabCorp is launching return-to-work services to help employers screen their staff for COVID-19, including antibody blood tests.

Copyright © 2020 LabPulse.com

Last Updated ls 7/27/2020 9:22:33 AM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current